Piramal Pharma Ltd
NSE:PPLPHARMA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
164.43
242.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 247.52 INR with a low forecast of 212.1 INR and a high forecast of 325.5 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PPLPHARMA's stock price target?
Price Target
247.52
INR
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 247.52 INR with a low forecast of 212.1 INR and a high forecast of 325.5 INR.
What is Piramal Pharma Ltd's Revenue forecast?
Projected CAGR
11%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's revenue is 44%. The projected CAGR for the next 3 years is 11%.
What is Piramal Pharma Ltd's Operating Income forecast?
Projected CAGR
19%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's operating income is -7%. The projected CAGR for the next 3 years is 19%.
What is Piramal Pharma Ltd's Net Income forecast?
Projected CAGR
107%
For the last 3 years the compound annual growth rate for Piramal Pharma Ltd's net income is -36%. The projected CAGR for the next 3 years is 107%.
